跳至主要内容
临床试验/ACTRN12618000508279
ACTRN12618000508279招募中1 期

Dose response measurements of the pupils to 0.01%, 0.02% and 0.05% atropine eye drops over time in healthy adults.

SW Sydney0 个研究点目标入组 56 人开始时间: 2018年4月9日最近更新:
适应症

试验速览

阶段
1 期
状态
招募中
发起方
入组人数
56

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 40 Years(—)
性别
All

入选标准

  • 1) Normal general and ocular health
  • 2) Adults aged 18-40 years
  • 3) No allergy to atropine or preservatives
  • 4) No history or risk of glaucoma

排除标准

  • 1) Recent atropine eye drop use prior to enrolment
  • 2) Any eye diseases including inflammation, infection or allergy
  • 3) History of allergic reaction to eye medications
  • 4) Risk of glaucoma
  • 5) Currently using any eye medications or systemic monoamine oxidase inhibitors (MAOIs)
  • 6) Women who are pregnant, planning to become pregnant or breastfeeding

研究者

发起方
SW Sydney

相似试验